辅酶Q10在各种神经退行性和精神疾病中的参与
Alireza Ebrahimi1, Amirhossein Kamyab2, Sahar Hosseini1
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Biochemistry research international
|November 10, 2023
概括
辅酶Q10 (CoQ10) 在能量代谢中起着至关重要的作用,并具有抗氧化特性. 研究表明,由于其保护作用,CoQ10可能为各种神经疾病提供治疗益处.
科学领域:
- 生物化学 生化学
- 神经科学是一个神经科学.
- 线粒体医学 线粒体医学
背景情况:
- 辅酶Q10 (CoQ10) 或泛基对于线粒体的能量生产和电子运输至关重要.
- 辅酶Q10存在于减少的 (ubiquinol) 和氧化的 (ubiquinone) 形式,作为抗氧化剂和自由基清除剂.
- 缺乏CoQ10与心血管,神经和癌症疾病有关.
研究的目的:
- 审查有关辅酶Q10 (CoQ10) 在神经疾病中的潜在治疗作用的文献.
- 为了突出CoQ10在保护神经系统免受退化方面的作用.
主要方法:
- 对研究辅酶Q10 (CoQ10) 和神经疾病的文献综述.
- 对CoQ10的生物化学特性进行分析,包括其抗氧化和能量调节功能.
主要成果:
- 辅酶Q10 (CoQ10) 在治疗心血管,神经肌肉和神经退行性疾病方面显示出潜在的益处.
- 有证据表明,CoQ10在预防和治疗帕金森病,阿尔茨海默病和ALS等疾病方面具有有效性.
- CoQ10的抗氧化剂和线粒体能量调节有助于神经保护.
结论:
- 辅酶Q10 (CoQ10) 显示出作为一系列神经系统疾病的治疗剂的前景.
- 需要进一步的研究来充分阐明CoQ10在神经学中的机制和临床应用.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Alzheimer's Disease: Overview
498
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498
Alzheimer's Disease: Treatment
197
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
197
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Role of Reduced Coenzymes NADH and FADH₂
11.7K
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
11.7K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K


